Frédéric Joël Desdouits

Frédéric Joël Desdouits

Directeur Général chez
Orano Med SAS
59 ans
Health Technology
Consumer Services
Commercial Services

Profil

Frédéric Joël Desdouits is CEO & Member-Governors Board at Orano Med Manufacturing SAS since 2026 and a Member of the Supervisory Board at Charles River Laboratories Evreux SAS. Former roles include Chief Executive Officer at PCAS SA from 2019 to 2020, Chief Executive Officer & Independent Director at TreeFrog Therapeutics SAS from 2019 to 2025, Director-Business Development at Pierre Fabre SA from 2011 to 2017, Managing Director at CU CHEMIE UETIKON GmbH from 2017 to 2020, Member at Sanofi from 2010 to 2011, Analyst at Exane SA (Broker) in 2004, Member-Supervisory Board at Exonhit from 2008 to 2011, Member-Supervisory Board at Genfit SA from 2014 to 2017, Managing Partner at Bionest Partners SAS from 2004 to 2011, and Partner at Bionest Partners Finance SAS from 2007 to 2011.
Education includes a doctorate from The Rockefeller University in 1996, a doctorate from College de France, graduate studies at Université Pierre et Marie Curie, and undergraduate studies at Ecole Polytechnique.

Postes actifs de Frédéric Joël Desdouits

SociétésPosteDébut
Directeur/Membre du Conseil -
Directeur Général 08/04/2026

Anciens postes connus de Frédéric Joël Desdouits

SociétésPosteFin
Directeur Général 15/12/2025
Directeur Général 25/06/2020
PCAS Directeur Général 23/03/2020
Corporate Officer/Principal 01/09/2017
Directeur/Membre du Conseil 01/09/2011
Voir l'expérience en détail de Frédéric Joël Desdouits

Formation de Frédéric Joël Desdouits

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

46

Relations au 1er degré

16

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées16

Health Technology

Health Technology

Health Technology

Commercial Services

Finance

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Process Industries

Consumer Services

Commercial Services

Bionest Partners Finance SAS

Commercial Services

Health Technology

  1. Bourse
  2. Insiders
  3. Frédéric Joël Desdouits